Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262516 · ClinicalTrials.gov registry record · NA
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
A NA study of Urothelial Carcinoma, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 4
- Study locations
NCT06262516 is a NA study of Urothelial Carcinoma that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 94 participants, below the 238-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (61% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT06262516, a NA study of Urothelial Carcinoma, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma. The main questions it aims to answer are: * To determine oncologic outcomes, specifically 2-year recurrence-free survival * To determine other oncologic outcomes including treatment-free, cancer-specific and overall survival * To determine time to recurrence and recurrence patterns * To determine use of adjuvant therapies * To determine perioperative complications Participants will undergo nephroureterectomy with or without lymph node dissection. Researchers will compare these two groups to determine the oncologic efficacy of performing lymph node dissection.
Conditions Studied
Interventions
- PROCEDURE Nephroureterectomy
- PROCEDURE Lymph Node Dissection
Study Locations (4)
Ohio
- University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center - Cleveland
- Cleveland Clinic Glickman Urological and Kidney Institute - Cleveland
Florida
- University of Florida Health Science Center - Gainesville
Illinois
- Southern Illinois University - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2024-05-17 |
| Est. Completion | 2029-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06262516
The ClinicalTrials.gov registry entry for NCT06262516 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 85 other Urothelial Carcinoma trials with a reported enrollment target (61% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urothelial Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Nephroureterectomy is the first listed.
NCT06262516 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Ohio, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT06262516 about?
NCT06262516 is a clinical study titled "Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma". The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma. The main questions it aims to answer are: * To determine oncologic outcomes, specifically 2-year recurr...
What is the current status of trial NCT06262516?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2024-05-17. Estimated completion is 2029-01-01.
What conditions does trial NCT06262516 study?
This clinical trial studies the following conditions: Urothelial Carcinoma.
What interventions are being tested in trial NCT06262516?
The interventions under investigation include: Nephroureterectomy (PROCEDURE), Lymph Node Dissection (PROCEDURE).
Who is sponsoring clinical trial NCT06262516?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262516 being conducted?
This trial has 4 study locations across Florida, Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urothelial Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RECRUITING · NA
-
Bladder Cancer Screening Trial
RECRUITING · NA
-
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RECRUITING · NA
-
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
RECRUITING · NA
-
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
RECRUITING · NA
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.